Y-mAbs Therapeutics, Inc. Common Stock

YMAB US9842411095

💰
Capitalization
Small-cap

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

🔗
Website
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
35
🙍
Insiders
9
Person Price Shares Total Published Completed
Gad Thomas
SR OFF 		5.23
USD 		10,810
Sold 		56,536
USD 		07/03/2025 07/03/2025
Gad Thomas
SR OFF 		12.97
USD 		30,000
Sold 		389,100
USD 		13/09/2024 16/09/2024
Gad Thomas
SR OFF 		13.47
USD 		65,000
Sold 		875,550
USD 		13/09/2024 13/09/2024
Lund-hansen Torben
VP 		15.37
USD 		50,000
Sold 		768,500
USD 		28/08/2024 28/08/2024
Wilms Joris
VP 		14.69
USD 		5,000
Sold 		73,450
USD 		26/08/2024 26/08/2024
Gad Thomas
SR OFF 		12.00
USD 		35,000
Sold 		420,000
USD 		10/06/2024 11/06/2024
Gad Thomas
SR OFF 		12.03
USD 		35,000
Sold 		421,050
USD 		10/06/2024 10/06/2024
Ber Gerard
O 		12.00
USD 		722
Sold 		8,664
USD 		10/06/2024 10/06/2024
Kruse Bo
EX VP 		12.07
USD 		31,371
Sold 		378,648
USD 		30/05/2024 31/05/2024
Kruse Bo
EX VP 		12.03
USD 		28,629
Sold 		344,407
USD 		30/05/2024 30/05/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Y-mAbs Therapeutics, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Gad Thomas 13 4,418,297.80 339,869.06 20/11/2023 07/03/2025
Wg Biotech Aps 8 2,074,891.71 259,361.46 27/11/2023 11/12/2023
Wedell-wedellsborg Johan 7 1,765,414.45 252,202.06 27/11/2023 11/12/2023
Lund-hansen Torben 1 768,500.00 768,500.00 28/08/2024 28/08/2024
Kruse Bo 2 723,054.84 361,527.42 30/05/2024 31/05/2024
Wilms Joris 1 73,450.00 73,450.00 26/08/2024 26/08/2024
Rajah Vignesh 1 28,282.83 28,282.83 05/03/2024 05/03/2024
Smith Susan Laura 1 27,837.10 27,837.10 05/03/2024 05/03/2024
Ber Gerard 1 8,664.00 8,664.00 10/06/2024 10/06/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies 3
Name ISIN Ticker
LANTHEUS HOLDINGS, INC. US5165441032 LNTH

3 the firms where the current insiders have executed transactions.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.